Oct 2023 Articles

Articles
Safety of bempedoic acid in patients at high cardiovascular risk and with statin intolerance
Bays HE, Bloedon LT, Lin G, et al.
Journal:
J Clin Lipidol

First published: October 31, 2023 DOI: 10.1016/j.jacl.2023.10.011
View
- Share
Articles
Lipoprotein(a)-60 Years Later-What Do We Know?
Pasławska A, Tomasik PJ
Journal:
Cells

First published: October 17, 2023 DOI: 10.3390/cells12202472
View
- Share
Articles
Performance of the ACC/AHA Pooled Cohort Cardiovascular Risk Equations in Clinical Practice
Medina-Inojosa JR, Somers VK, Garcia M, et al.
Journal:
J Am Coll Cardiol

First published: October 10, 2023 DOI: 10.1016/j.jacc.2023.07.018
View
- Share
Articles
Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality
Global Cardiovascular Risk Consortium; Magnussen C, Ojeda FM, et al.
Journal:
N Engl J Med

First published: October 5, 2023 DOI: 10.1056/NEJMoa2206916
View
- Share
Articles
A comparison of laboratory-based and office-based Framingham risk scores to predict 10-year risk of cardiovascular diseases: a population-based study
Dehghan A, Ahmadnia Motlagh S, Khezri R, et al.
Journal:
J Transl Med

First published: October 3, 2023 DOI: 10.1186/s12967-023-04568-8
View
- Share
Articles
LDL-C Reduction With Lipid-Lowering Therapy for Primary Prevention of Major Vascular Events Among Older Individuals
Andersson NW, Corn G, Dohlmann TL, et al.
Journal:
J Am Coll Cardiol

First published: October 3, 2023 DOI: 10.1016/j.jacc.2023.07.027
View
- Share
Articles
The Time to Initiate Anti-Inflammatory Therapy for Patients With Chronic Coronary Atherosclerosis Has Arrived
Ridker PM
Journal:
Circulation

First published: October 2, 2023 DOI: 10.1161/CIRCULATIONAHA.123.066510
View
- Share

Oct 2023 Articles

Articles

Safety of bempedoic acid in patients at high cardiovascular risk and with statin intolerance

Bays HE, Bloedon LT, Lin G, et al.

Articles

Lipoprotein(a)-60 Years Later-What Do We Know?

Pasławska A, Tomasik PJ

Articles

Performance of the ACC/AHA Pooled Cohort Cardiovascular Risk Equations in Clinical Practice

Medina-Inojosa JR, Somers VK, Garcia M, et al.

Articles

Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality

Global Cardiovascular Risk Consortium; Magnussen C, Ojeda FM, et al.

Articles

A comparison of laboratory-based and office-based Framingham risk scores to predict 10-year risk of cardiovascular diseases: a population-based study

Dehghan A, Ahmadnia Motlagh S, Khezri R, et al.

Articles

LDL-C Reduction With Lipid-Lowering Therapy for Primary Prevention of Major Vascular Events Among Older Individuals

Andersson NW, Corn G, Dohlmann TL, et al.

Articles

The Time to Initiate Anti-Inflammatory Therapy for Patients With Chronic Coronary Atherosclerosis Has Arrived

Ridker PM

Articles

Safety of bempedoic acid in patients at high cardiovascular risk and with statin intolerance

Bays HE, Bloedon LT, Lin G, et al.

Share

Articles

Lipoprotein(a)-60 Years Later-What Do We Know?

Pasławska A, Tomasik PJ

Share

Articles

Performance of the ACC/AHA Pooled Cohort Cardiovascular Risk Equations in Clinical Practice

Medina-Inojosa JR, Somers VK, Garcia M, et al.

Share

Articles

Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality

Global Cardiovascular Risk Consortium; Magnussen C, Ojeda FM, et al.

Share

Articles

A comparison of laboratory-based and office-based Framingham risk scores to predict 10-year risk of cardiovascular diseases: a population-based study

Dehghan A, Ahmadnia Motlagh S, Khezri R, et al.

Share

Articles

LDL-C Reduction With Lipid-Lowering Therapy for Primary Prevention of Major Vascular Events Among Older Individuals

Andersson NW, Corn G, Dohlmann TL, et al.

Share

Articles

The Time to Initiate Anti-Inflammatory Therapy for Patients With Chronic Coronary Atherosclerosis Has Arrived

Ridker PM

Share